vs
Assertio Holdings, Inc.（ASRT）与PROVIDENT FINANCIAL HOLDINGS INC（PROV）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是PROVIDENT FINANCIAL HOLDINGS INC的1.4倍（$13.5M vs $9.8M），PROVIDENT FINANCIAL HOLDINGS INC同比增速更快（2.5% vs -57.9%），过去两年PROVIDENT FINANCIAL HOLDINGS INC的营收复合增速更高（2.3% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
普罗维登特金融控股公司是一家银行控股企业，通过旗下全资子公司普罗维登特储蓄银行开展业务，为美国加利福尼亚州当地社区提供各类存款、住房抵押贷款、消费贷款、小微企业融资等零售及商业金融服务。
ASRT vs PROV — 直观对比
营收规模更大
ASRT
是对方的1.4倍
$9.8M
营收增速更快
PROV
高出60.4%
-57.9%
两年增速更快
PROV
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $9.8M |
| 净利润 | — | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 20.8% |
| 净利率 | — | 14.6% |
| 营收同比 | -57.9% | 2.5% |
| 净利润同比 | — | 64.7% |
| 每股收益（稀释后） | $-4.54 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTPROV
| Q4 25 | $13.5M | $9.8M | ||
| Q3 25 | $49.5M | $9.7M | ||
| Q2 25 | $29.2M | $9.8M | ||
| Q1 25 | $26.5M | $10.1M | ||
| Q4 24 | $32.2M | $9.6M | ||
| Q3 24 | $29.2M | $9.5M | ||
| Q2 24 | $31.1M | $9.9M | ||
| Q1 24 | $32.4M | $9.4M |
净利润ASRTPROV
| Q4 25 | — | $1.4M | ||
| Q3 25 | $11.4M | $1.7M | ||
| Q2 25 | $-16.4M | $1.6M | ||
| Q1 25 | $-13.5M | $1.9M | ||
| Q4 24 | — | $872.0K | ||
| Q3 24 | $-2.9M | $1.9M | ||
| Q2 24 | $-3.7M | $2.0M | ||
| Q1 24 | $-4.5M | $1.5M |
营业利润率ASRTPROV
| Q4 25 | -86.7% | 20.8% | ||
| Q3 25 | 23.2% | 28.1% | ||
| Q2 25 | -27.5% | 23.6% | ||
| Q1 25 | -50.0% | 26.2% | ||
| Q4 24 | -41.9% | 12.7% | ||
| Q3 24 | -10.4% | 28.3% | ||
| Q2 24 | -11.6% | 27.8% | ||
| Q1 24 | -13.4% | 22.5% |
净利率ASRTPROV
| Q4 25 | — | 14.6% | ||
| Q3 25 | 23.1% | 17.3% | ||
| Q2 25 | -56.0% | 16.7% | ||
| Q1 25 | -51.1% | 18.4% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | -10.0% | 20.0% | ||
| Q2 24 | -11.8% | 19.7% | ||
| Q1 24 | -13.9% | 15.9% |
每股收益（稀释后）ASRTPROV
| Q4 25 | $-4.54 | $0.22 | ||
| Q3 25 | $0.11 | $0.25 | ||
| Q2 25 | $-0.17 | $0.24 | ||
| Q1 25 | $-0.14 | $0.28 | ||
| Q4 24 | $-3.28 | $0.13 | ||
| Q3 24 | $-0.03 | $0.28 | ||
| Q2 24 | $-0.04 | $0.28 | ||
| Q1 24 | $-0.05 | $0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $54.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $127.5M |
| 总资产 | $267.0M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTPROV
| Q4 25 | $63.4M | $54.4M | ||
| Q3 25 | $93.4M | $49.4M | ||
| Q2 25 | $98.2M | $53.1M | ||
| Q1 25 | $87.3M | $50.9M | ||
| Q4 24 | $100.1M | $45.5M | ||
| Q3 24 | $88.6M | $48.2M | ||
| Q2 24 | $88.4M | $51.4M | ||
| Q1 24 | $80.7M | $51.7M |
总债务ASRTPROV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTPROV
| Q4 25 | $94.0M | $127.5M | ||
| Q3 25 | $105.8M | $128.4M | ||
| Q2 25 | $93.3M | $128.5M | ||
| Q1 25 | $108.5M | $128.9M | ||
| Q4 24 | $121.1M | $128.6M | ||
| Q3 24 | $130.5M | $129.6M | ||
| Q2 24 | $132.2M | $129.9M | ||
| Q1 24 | $134.5M | $129.5M |
总资产ASRTPROV
| Q4 25 | $267.0M | $1.2B | ||
| Q3 25 | $319.8M | $1.2B | ||
| Q2 25 | $273.8M | $1.2B | ||
| Q1 25 | $286.4M | $1.3B | ||
| Q4 24 | $284.7M | $1.3B | ||
| Q3 24 | $276.0M | $1.3B | ||
| Q2 24 | $279.4M | $1.3B | ||
| Q1 24 | $282.0M | $1.3B |
负债/权益比ASRTPROV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $1.2M |
| 自由现金流经营现金流 - 资本支出 | — | $1.0M |
| 自由现金流率自由现金流/营收 | — | 10.5% |
| 资本支出强度资本支出/营收 | — | 1.9% |
| 现金转化率经营现金流/净利润 | — | 0.85× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流ASRTPROV
| Q4 25 | $-30.0M | $1.2M | ||
| Q3 25 | $-4.8M | $2.5M | ||
| Q2 25 | $19.1M | $8.7M | ||
| Q1 25 | $-12.5M | $3.3M | ||
| Q4 24 | $11.5M | $324.0K | ||
| Q3 24 | $-35.0K | $2.6M | ||
| Q2 24 | $7.4M | $5.7M | ||
| Q1 24 | $7.5M | $3.0M |
自由现金流ASRTPROV
| Q4 25 | — | $1.0M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $8.2M | ||
| Q1 25 | — | $3.3M | ||
| Q4 24 | — | $307.0K | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | $4.1M | ||
| Q1 24 | — | $2.6M |
自由现金流率ASRTPROV
| Q4 25 | — | 10.5% | ||
| Q3 25 | — | 25.2% | ||
| Q2 25 | — | 83.5% | ||
| Q1 25 | — | 32.5% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 41.3% | ||
| Q1 24 | — | 27.5% |
资本支出强度ASRTPROV
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 0.0% | 1.8% | ||
| Q2 24 | — | 16.0% | ||
| Q1 24 | — | 4.2% |
现金转化率ASRTPROV
| Q4 25 | — | 0.85× | ||
| Q3 25 | -0.42× | 1.48× | ||
| Q2 25 | — | 5.34× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | 0.37× | ||
| Q3 24 | — | 1.35× | ||
| Q2 24 | — | 2.91× | ||
| Q1 24 | — | 2.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
PROV
暂无分部数据
